SCHEMBL25301021

SCHEMBL25301021

CC(F)(F)C(=O)c1c(F)ccnc1Cl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATR Q13535 1/20 0.34
RAB9A P51151 2/20 0.33
ANO1 Q5XXA6 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.33
GPBAR1 Q8TDU6 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ASPH Q12797 1/20 0.32
KDM8 Q8N371 1/20 0.32
JAK2 O60674 1/20 0.31
JAK1 P23458 1/20 0.31
TYK2 P29597 1/20 0.31
S1PR3 Q99500 1/20 0.31
SMARCA2 P51531 1/20 0.31
SMARCA4 P51532 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30047616 0.77 ALDH1A1 (0.39) RAB9ASMN1; SMN2LMNATDP1KDM4E
SCHEMBL1478308 0.77 SMN1; SMN2 (0.46) SMN1; SMN2LMNAMAPTKDM4EASPH
SCHEMBL28846830 0.75 POLB (0.38) RAB9ASMN1; SMN2LMNAKDM4EASPH
SCHEMBL23857602 0.75 ATR (0.43) ATRLMNATDP1MAPTKDM4E
SCHEMBL25259786 0.72 LMNA (0.34) RAB9ASMN1; SMN2LMNATDP1KDM4E
SCHEMBL22385053 0.72 NPC1 (0.33) RAB9ALMNAGAAMAPT
SCHEMBL6710903 0.71 LMNA (0.58) SMN1; SMN2LMNATDP1POLBHTT
SCHEMBL16797411 0.71 CA12 (0.45) RAB9ASMN1; SMN2LMNATDP1GAA
SCHEMBL25302396 0.70 CES1 (0.35) SMN1; SMN2LMNAGAAMAPTNPSR1
SCHEMBL26054410 0.70 ATR (0.36) ATRANO1SMN1; SMN2LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12565497-B2 Sulfone derivatives HOFFMANN-LA ROCHE INC. (US) 2026-03-03 US disclosed
US-20230219953-A1 SULFONE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-07-13 US disclosed
CN-115916756-A Sulfone derivative 豪夫迈·罗氏有限公司 2023-04-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219953-A1 SULFONE DERIVATIVES SULT1E1, SULT1A1, SULT2A1 ATR 4431/4885RAB9A 1637/4885ANO1 2563/4885
US-12565497-B2 Sulfone derivatives CXCR1, CCR1, SULT1E1 ATR 4381/4885RAB9A 2871/4885ANO1 843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.